MedTrace Logo

Addressing Cancer-Related Distress Through Survivorship Care in Community Oncology

NCT07673731 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-06-29

No results posted yet for this study

Summary

The goal of this study is to understand whether providing a structured survivorship care visit at the beginning of cancer treatment is associated with changes in distress and quality of life in adults with cancer receiving treatment in a community oncology clinic. The main questions it aims to answer are:

* Is participation in a structured survivorship visit at the start of active treatment associated with changes in psychological distress?
* Is participation in the survivorship visit associated with changes in quality of life?

Participants will:

* Be asked to complete questionnaires about their level of distress and overall quality of life.
* Participate in a single survivorship visit with the clinic's Physician Assistant at the Ellis Medical Oncology Clinic.
* Complete the same questionnaires again approximately two weeks and one month after the survivorship visit.

Conditions

  • Psychosocial Distress
  • Cancer

Interventions

BEHAVIORAL

Structured Survivorship Visit

A structured survivorship care visit conducted by a trained Physician Assistant during the beginning of active cancer treatment. The visit uses patient-reported distress screening results to guide discussion of psychosocial, physical, practical, and supportive care needs. Counseling, education, care coordination, and referrals may be provided as appropriate within routine clinical practice.

Sponsors & Collaborators

  • Ellis Medicine

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-01-31
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673731 on ClinicalTrials.gov